http://www.hairsite.com/hair-loss/forum ... 51409.html[/url]
It was in that post that he made his comment about you Bryan! Quote:
"The other important thing about your article is that you provide a method
to test its validity, That is not something that eccentric people do (I saw
that unfortunate comment about your posting which came out of the blue and
I was surprised that a seemingly intelligent person would resort to such
insults for no reason and without apparent provocation). Eccentric people
are beyond proving their statements and they are also never wrong (at least
they will never admit to being wrong)"
Says it all
Bryan said:
S Foote. said:
Point two, if you are so confident about this "slam dunk" Sawaya study, why wont you post this? Talk is cheap :whistle:
I've already posted it a long time ago, back when we were talking about this stuff a few years ago. It had to do with Sawaya's careful measurement of various follicular androgen-related cellular substances and growth-components, and how they were greatly affected by the application (or non-application) of RU58841. That's what was so convincing, the other poster called it a "slam dunk" that it's the
direct action of androgens on scalp hair follicles which suppresses their growth.
Still no link then
I pressume this was another of the irrelevant in-vitro studies. Irrelevant for two reasons, first follicle cells behave very differently in-vitro than in-vivo, even in the complete absence of androgens. Even the culture method itself changes characteristics.
Initial Characterisation of a New Model of
Dermal Papilla Cell Culture
C. Higgins1, G. Richardson1, G. Westgate2, M. Green3,
D.J. Tobin4, C. Jahoda1
Human dermal papilla (DP) cells grown in culture have been studied
extensively. However, some key differences between DP cell
behaviour in vivo and in culture have been identified. Smooth muscle
actin (SMA) is a sheath-cell specific marker in vivo, but once in
culture both papilla and sheath cells express SMA. Cells derived
from anagen DP’s are highly proliferative whilst the same cells in vivo
do not proliferate. Expression of extracellular matrix proteoglycans
changes during the hair cycle. The chondroitin proteoglycan Bamacan
is expressed in the anagen DP yet lost on entry to catagen and telogen
whilst Syndecan-1 is absent in anagen but present in the telogen DP.
In contrast, Perlecan expression remains constant throughout the hair
cycle. We previously demonstrated that DP cells grown in suspension
culture in tiny volumes form small spheroids which appear morphologically
to be more akin to DP found in vivo. We have now investigated
the differences between the two culture conditions using the
expression profile of SMA, proteoglycans and markers of proliferation.
Human DP cells at P4/P5 were plated in 35 mm dishes or placed
in hanging drops. All cells were cultured in MEM containing 10%
FBS. Cells were harvested when 80–90% confluent whilst spheres
were harvested after 30 h in culture. The two culture methods were
compared using RT-PCR and immuno-cytochemistry. The integrity
and viability of the spheres was confirmed using TEM and viability
markers. Results show that dermal spheres have a different profile
from normally cultured DP cells suggesting spheres may be an interesting
new model for studying DP cells in vitro. Perlecan and
Syndecan-1 expression is similar in both cells and dermal spheres in
contrast to Bamacan which is reduced in dermal spheres. SMA and
Ki67 are expressed in DP cells but not in dermal spheres, even though
the spheres remained viable.
Secondly the well discussed immuno mouse study were human male pattern baldness follicles regrow (you know the one i mean
) completely overruled any rellevance of the in-vitro studies as i and others have explained to you many times.
So much for your great "slam dunk"